|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 270, Issue 3 621-R629, Copyright © 1996 by American Physiological Society
ARTICLES |
J. Fan, M. M. Wojnar, M. Theodorakis and C. H. Lang
Department of Surgery, State University of New York at Stony Brook 11794-8191, USA.
The purpose of the present study was to determine whether interleukin (IL)-1 would alter the insulin-like growth factor (IGF) system in rats and whether this change was mediated by glucocorticoids. The IGF-I concentration was decreased in plasma (32%), liver (35%), skeletal muscle (40-50% depending on fiber type), pituitary (36%), and brain (52%), and increased in kidney (73%) 6 h after intravenous injection of IL-1 beta. IL-1 beta also decreased IGF-I mRNA levels in liver and muscle and increased expression in kidney. These changes were associated with a > 2.5-fold elevation in plasma corticosterone levels. Pretreatment of rats with the glucocorticoid receptor antagonist RU-486 prevented the IL-1 beta-induced decrease in plasma and liver IGF-I concentration and the reduction in hepatic IGF-I mRNA expression. In contrast, RU-486 did not significantly attenuate the fall in IGF-I content in skeletal muscle, heart, brain, or pituitary or the increase in IGF-I observed in kidney after IL-1 beta. Furthermore, pretreatment with RU-486 did not completely prevent the IL-1 beta-induced decrease in IGF-I mRNA in skeletal muscle. The concentration of both IGF-binding protein (BP)-1 and BP-2 was increased in plasma, liver, and muscle in response to IL-1 beta, and these changes were also not prevented by RU-486. These results indicate that the inflammatory cytokine IL-1 beta is capable of influencing multiple components of the IGF system. Whereas the enhanced endogenous production of glucocorticoids appears to mediate the IL-1 beta-induced decrease in IGF-I synthesis in liver, the changes in IGF-I content observed in other tissues and the increase in IGFBP-1 and IGFBP-2 appear to be largely glucocorticoid independent.
This article has been cited by other articles:
![]() |
T. C. Vary, R. A. Frost, and C. H. Lang Acute alcohol intoxication increases atrogin-1 and MuRF1 mRNA without increasing proteolysis in skeletal muscle Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1777 - R1789. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Soeki, I. Kishimoto, D. O. Schwenke, T. Tokudome, T. Horio, M. Yoshida, H. Hosoda, and K. Kangawa Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H426 - H432. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Ahmed, M. D. Buzzelli, C. H. Lang, J. B. Capen, M. L. Shumate, M. Navaratnarajah, M. Nagarajan, and R. N. Cooney Interleukin-6 inhibits growth hormone-mediated gene expression in hepatocytes Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1793 - G1803. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Frost, G. J. Nystrom, L. S. Jefferson, and C. H. Lang Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E501 - E512. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Lang, D. Huber, and R. A. Frost Burn-induced increase in atrogin-1 and MuRF-1 in skeletal muscle is glucocorticoid independent but downregulated by IGF-I Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R328 - R336. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nemet, A. Eliakim, F. Zaldivar, and D. M. Cooper Effect of rhIL-6 infusion on GH->IGF-I axis mediators in humans Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1663 - R1668. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Lang, B. J. Krawiec, D. Huber, J. M. McCoy, and R. A. Frost Sepsis and inflammatory insults downregulate IGFBP-5, but not IGFBP-4, in skeletal muscle via a TNF-dependent mechanism Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R963 - R972. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Shumate, G. Yumet, T. A. Ahmed, and R. N. Cooney Interleukin-1 inhibits the induction of insulin-like growth factor-I by growth hormone in CWSV-1 hepatocytes Am J Physiol Gastrointest Liver Physiol, August 1, 2005; 289(2): G227 - G239. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nemet, Y. Oh, H.-S. Kim, M. Hill, and D. M. Cooper Effect of Intense Exercise on Inflammatory Cytokines and Growth Mediators in Adolescent Boys Pediatrics, October 1, 2002; 110(4): 681 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Adams Exercise Effects on Muscle Insulin Signaling and Action: Invited Review: Autocrine/paracrine IGF-I and skeletal muscle adaptation J Appl Physiol, September 1, 2002; 93(3): 1159 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yumet, M. L. Shumate, P. Bryant, C.-M. Lin, C. H. Lang, and R. N. Cooney Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E472 - E481. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Frost, G. J. Nystrom, and C. H. Lang Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2002; 283(3): R698 - R709. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Lang, G. J. Nystrom, and R. A. Frost Burn-induced changes in IGF-I and IGF-binding proteins are partially glucocorticoid dependent Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R207 - R215. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hoeflich, R. Reisinger, H. Lahm, W. Kiess, W. F. Blum, H. J. Kolb, M. M. Weber, and E. Wolf Insulin-like Growth Factor-binding Protein 2 in Tumorigenesis: Protector or Promoter? Cancer Res., December 1, 2001; 61(24): 8601 - 8610. [Full Text] [PDF] |
||||
![]() |
P. TIRAKITSOONTORN, E. NUSSBAUM, C. MOSER, M. HILL, and D. M. COOPER Fitness, Acute Exercise, and Anabolic and Catabolic Mediators in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1432 - 1437. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Laugero and G. P. Moberg Summation of behavioral and immunological stress: metabolic consequences to the growing mouse Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E44 - E49. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Lang, X. Liu, G. J. Nystrom, and R. A. Frost Acute response of IGF-I and IGF binding proteins induced by thermal injury Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1087 - E1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Lackey, S. L. Gray, and D. M. Henricks Does the Insulin-Like Growth Factor System Interact with Prostaglandins and Proinflammatory Cytokines During Neurodegeneration? Experimental Biology and Medicine, May 1, 2000; 224(1): 20 - 27. [Abstract] [Full Text] |
||||
![]() |
Y. R. Boisclair, J. Wang, J. Shi, K. R. Hurst, and G. T. Ooi Role of the Suppressor of Cytokine Signaling-3 in Mediating the Inhibitory Effects of Interleukin-1beta on the Growth Hormone-dependent Transcription of the Acid-labile Subunit Gene in Liver Cells J. Biol. Chem., February 11, 2000; 275(6): 3841 - 3847. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Loddick and N. J. Rothwell Mechanisms of tumor necrosis factor alpha action on neurodegeneration: Interaction with insulin-like growth factor-1 PNAS, August 17, 1999; 96(17): 9449 - 9451. [Full Text] [PDF] |
||||
![]() |
M. Varedi, G. H. Greeley Jr., D. N. Herndon, and E. W. Englander A thermal injury-induced circulating factor(s) compromises intestinal cell morphology, proliferation, and migration Am J Physiol Gastrointest Liver Physiol, July 1, 1999; 277(1): G175 - G182. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Farrell, M. J. Fedele, T. C. Vary, S. R. Kimball, C. H. Lang, and L. S. Jefferson Regulation of protein synthesis after acute resistance exercise in diabetic rats Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E721 - E727. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Lang, G. J. Nystrom, and R. A. Frost Regulation of IGF binding protein-1 in Hep G2 cells by cytokines and reactive oxygen species Am J Physiol Gastrointest Liver Physiol, March 1, 1999; 276(3): G719 - G727. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Wojnar, J. Fan, Y. H. Li, and C. H. Lang Endotoxin-induced changes in IGF-I differ in rats provided enteral vs. parenteral nutrition Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E455 - E464. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Defalque, N. Brandt, J.-M. Ketelslegers, and J.-P. Thissen GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E565 - E572. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Lang, R. A. Frost, J. Ejiofor, D. B. Lacy, and O. P. McGuinness Hepatic production and intestinal uptake of IGF-I: response to infection Am J Physiol Gastrointest Liver Physiol, December 1, 1998; 275(6): G1291 - G1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Fang, B.-G. Li, J. J. Wang, J. E. Fischer, and P.-O. Hasselgren Treatment of burned rats with insulin-like growth factor I inhibits the catabolic response in skeletal muscle Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R1091 - R1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Lang, J. Fan, M. M. Wojnar, T. C. Vary, and R. Cooney Role of central IL-1 in regulating peripheral IGF-I during endotoxemia and sepsis Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1998; 274(4): R956 - R962. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |